Editor's PickMarket News

NA Proactive news snapshot: SoLVBL Solutions, Medallion Resources, Golden Arrow Resources, PharmaDrug, NorthWest Copper …

SoLVBL Solutions Inc said due to oversubscribed investor demand it has upsized and closed its previously announced brokered private placement for $3 million. The company issued 50 million units priced at $0.06 each and the private placement was brokered by Research Capital Corporation, who served as both sole agent and bookrunner. Each unit consists of one common share of SoLVBL Solutions and one common share purchase warrant, exercisable for a period of 24 months in exchange for one common share with a purchase price of $0.12 per warrant share. Medallion Resources Ltd has announced a tie-up with private company ACDC Metals Pty Ltd (ACDC) to potentially produce rare earths from monazite from Australia’s Murray Basin using the former’s extraction process. ACDC is to acquire three historical non-JORC/NI43-101 compliant mineral sand resource properties and other exploration assets in Victoria, Australia, and is planning to undertake an IPO and list on the Australian Stock Exchange within the next 12 months. The non-binding letter of intent (LOI) gives ACDC the exclusive right to construct a mineral sand monazite refinery in southeastern Australia utilizing the Medallion monazite process, and the right to sub-license the Ligand (NASDAQ:LGND) Assisted Displacement (LAD) Chromatography process to separate out the rare earth elements (REE). Golden Arrow Resources Corporation has commenced an exploration program, including an Induced Polarization Resistivity (IPR) survey at its wholly-owned Yanso Gold Project. Located in San Juan province, Argentina, Yanso is described as a gold-copper intrusive-related target with a 300 metres (m) by 90m zone of strong alteration coincident with gold and other geochemical anomalies.  A previous exploration effort at the gold property returned positive assay results from rock chip samples. Highlights of this work include a 16m zone averaging 0.602 grams per ton (g/t) gold (including 2m at 1.27 g/t gold); as well as 2m averaging 3.46 g/t gold, and 2m averaging 3.15 g/t gold. PharmaDrug Inc will have a new look for traders starting in August. The pharmaceutical company announced it is changing its Canadian ticker symbol from ‘BUZZ’ to ‘PHRX’ to better align with its strategy.  NorthWest Copper (TSX-V:NWST) Corp has announced the start of the first drill program at its East Niv property in central British Columbia. The company said an initial program of 11 holes for a total of 2,750 metres (m) is planned. In addition to diamond drilling, NorthWest Copper (TSX-V:NWST) said it is continuing to explore the broader East Niv region and carrying out fieldwork to identify additional new targets for follow-up. Cloud DX (TSX-V:CDX, OTCQB:CDXFF) (TSX-V:CDX, OTCQB:CDXFF) Inc, a provider of virtual care and remote patient monitoring solutions, has reaffirmed its commitment to gender diversity and professional equality between men and women. The North American disruptor in virtual care based in Kitchener, Ontario and Brooklyn, New York, said individuals who identify as female currently make up over 50% of Cloud DX (TSX-V:CDX, OTCQB:CDXFF) employees and contractors. The company is also proud that it has “strong representation” from individuals who identify as female and estimated that one out of four of its executives is female, while three out of five people in the senior leadership team are women.  “Since our inception as a company, we have strongly advocated for gender equality, diversity and inclusion,” said Cloud DX CEO Robert Kaul in a statement. Acasti Pharma Inc (TSX-V:ACST, NASDAQ:ACST) said it will host a business update conference call on August 4, 2021 at 1:00 pm ET to discuss the planned acquisition of Grace Therapeutics Inc, a privately held emerging biopharmaceutical company focused on developing innovative drug delivery technologies for the treatment of rare and orphan diseases. Acasti plans to provide additional context on the proposed Grace acquisition and its benefits, including Grace’s diversified drug pipeline with multiple, high quality clinical assets, significant addressable market opportunities, three clinical stage assets with a potentially shorter timeline to key milestones, efficient and lower-cost clinical and regulatory pathway and and a strong and growing intellectual property portfolio. The conference call will be available via telephone by dialing toll free 844-369-8770 for US callers or +1 862-298-0840 for international callers. The conference call will be webcasted and available at https://www.webcaster4.com/Webcast/Page/2210/42244, or on the firm’s investors section of the website: https://www.acastipharma.com/investors/. Forian (NASDAQ:FORA) Inc. has said it will announce its financial results for the three months ended June 30, 2021, on Thursday, August 12, 2021, after the close of the market. The company will host a conference call at 4.30pm ET on August 12, 2021, to discuss the results. To access the conference call, from the US dial (833) 942-2345 or for International calls dial (270) 215-9807, and enter Conference ID 8092029. This information is also available on the company’s website at www.Forian (NASDAQ:FORA).com/investors. The earnings release along with a replay of the call promptly following its conclusion will be available at the same site. American Manganese Inc. (TSX-V:AMY, OTCQB:AMYZF) has announced that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (DTC). DTC is a subsidiary of the Depository Trust & Clearing Corp. that manages the electronic clearing and settlement of publicly traded companies in the United States. DTC eligibility reduces costs and accelerates the settlement process for investors and brokers allowing the Company’s common shares to be traded over a much wider selection of brokerage firms. “DTC eligibility is an important step in the maturity of AMY and our ongoing efforts to present the Company to a broader audience of potential investors,” said Larry Reaugh CEO and president of American Manganese. “With greater accessibility and visibility of AMY’s common shares, existing and new shareholders are provided with further opportunities to invest in our planned growth.”